Company intelligence / Profile preview

Liberty Strategic Capital

Washington, DC, United States

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Liberty Strategic Capital is a private equity firm focused on investing in global technology, financial services/fintech, cybersecurity, and content platforms. It does not conduct therapeutic R&D or clinical trials and has no clinical results or pipeline related to life sciences.

Industry: Investors

Partnerships

Cybereason (cybersecurity)New York Community Bancorp (banking/fintech)Satellogic (satellites)Zimperium (mobile security)BlueVoyant (cyber defense)Contrast Security (software security)

Beyond the preview

Go deeper on Liberty Strategic Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liberty Strategic Capital.

Explore the full profile